ASCO 2020：11项中国学术研究入选口头报告，17项Poster报告

受全球另行冠疫情受到影响，按计划于5月末29日~6月末2日在芝加哥召开的美国病理研究工作则会（ASCO）年则会上周将首次以线上形式举办，这是目前最大规模的线上盛则会。如今，联席则会议的概要题目公布，共103个sessions，中则会国共有11项研究工作崭露头角口头报告，17项崭露头角Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

巯基替尼或希亚替尼加卡培他滨运用于HER2+白血病乳腺胰脏（PHOEBE）：一项III期随机实验。

三场：白血病乳腺胰脏

著者：中则会国医学科学院疗养院徐兵河讲师、马飞讲师，上海交通大学附属疗养院胡夕春讲师等

概要号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可手术三阴性乳腺胰脏标准外科手术后卡培他滨维持拍子治疗的III期实验（SYSUCC-001）。

三场：乳腺胰脏—暂时性/周围/除此以外外科手术

著者：中则会山大学预防中则会心王之树森讲师等

概要号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

利用白血病小脑的表型形态来数据分析小脑脊液中则会尿素DNA扫描的不确定性: 另行高效率的发展软件对抗老击倒

三场：另行高效率的发展软件化解老问题

著者：李美芹 李科克等

概要号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

多纳非尼对比索拉非尼作为中后期肝肝细胞胰脏的一线外科手术：一项开放日标签、随机、多中则会心II/III期实验。

三场：上皮细胞胰脏—十二指肠食管、癌变和实为

著者：重庆大学伊万基夫齐疗养院毕锋讲师、中则会国团结解放军南昌疗养院秦叔逵讲师等

概要号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

中则会国中后期肝胰脏病症阿帕替尼中卫外科手术：一项随机、安慰剂依此、结果表明III期研究工作

三场：上皮细胞胰脏—十二指肠食管、癌变和实为

著者：中则会国团结解放军南昌疗养院秦叔逵讲师、重庆大学伊万基夫齐疗养院李秋讲师等

概要号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

中后期风湿热卵巢胰脏二次肝细胞减灭术的一项随机III期实验：SOC1 / SGOG-OV2。

不定期：护理人员肺胰脏

著者：上海交通大学附属中则会山疗养院臧荣余讲师等

概要：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈胰脏根治性子宫切除术后除此以外外科手术中则会的序贯放治疗对比单独放疗或同步放治疗（STARS研究工作）：一项随机、依此、开放日标签的III期实验。

联席则会议：护理人员肺胰脏

著者：中则会山大学预防中则会心马尔季尼夫卡讲师、刘继红讲师等

概要号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：除此以外吉非替尼对比治疗运用于可切除的EGFR基因型的N1-N2期NSCLC-随机III期病理实验的事与愿违总体猎食比对。

不定期：肺胰脏—非小肝细胞暂时性-周围/小肝细胞/其他腿部

著者：广东省团结疗养院吴一龙讲师等

概要号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR基因型寡移转到非小肝细胞肺胰脏病症一线色氨酸嘌呤抑制协同或不协同更进一步前线暂时性放疗：III期开放日标签病理随机实验（SINDAS）的中则会期结果（NCT02893332）。

不定期：肺胰脏-非小肝细胞移转到

著者：四川团结疗养院曾铭讲师等

概要：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对某类被害-1（PD-1）的人源化IgG4酵母协同阿昔替尼运用于白血病黏膜卵巢癌病症的Ib期研究工作的总猎食期和生物；也比对。

不定期：卵巢癌/皮肤胰脏

著者：北京大学疗养院郭军、盛锡楠讲师等

概要：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的可靠度和结果：通用CAR-T肝细胞首次消化系统实验外科手术患/难治性T肝细胞急性淋巴肝细胞乳癌（r/r T-ALL）的可靠度和。联席则会议：技术开发中则会的外科手术高效率-免疫外科手术。著者：王之欣欣等概要：3013名片：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利抗病毒在中后期食管楔形肝细胞胰脏病症中则会的高效率的发展：一项随机的开放日标签II期实验（ORIENT-2）。联席则会议：上皮细胞胰脏-十二指肠食管胰脏、癌变胰脏和实为道胰脏著者：徐建明讲师等概要：4511名片：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D特异性CAR-T肝细胞对髓母肝细胞瘤的根除性外科手术联席则会议：中则会枢神经系统著者：代红久、孙斌、杨东、徐晖、朱晶晶、魏佳、赵旭东概要：2522名片。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在中后期错配修复缺陷病症中则会的高效率的发展联席则会议：技术开发中则会的外科手术学-免疫外科手术著者：沈琳讲师等概要：3021名片。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 complexCD7-CART外科手术患/难治性ACUTE淋巴肝细胞乳癌/帕金森氏症的唯一未消化系统病理实验联席则会议: 技术开发性外科手术学-免疫外科手术著者简介：张明志，杨林等概要：3026名片: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 西米替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度衍生物（T）协同应运用于中后期实体瘤病症的Ib期研究工作联席则会议：发展性外科手术学--大分子靶向药物和生物化学著者：龚继芳，沈琳讲师等概要：3523名片：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin协同紫杉醇和nedaplatin外科手术风湿热或白血病食管楔形肝细胞胰脏（ESCC）病症的II期研究工作。联席则会议：上皮细胞胰脏-十二指肠食管、癌变和实为道胰脏的研究工作著者：王之志不强，李玉红，王之德申，王之凤华，任超，谭琼 王之志不强、李玉红、王之德深、王之凤华、任超、谭琼概要：4522名片：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.联席则会议：上皮细胞胰脏-十二指肠食管胰脏、癌变胰脏和实为管胰脏的中卫外科手术著者：宋艳等概要：4524名片：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种肾脏外体网状RNA确定性运用于初始活检时扫描高等级胰脏的肾脏外体网状RNA确定性：一项多中则会心的回顾性研究工作联席则会议：泌尿生殖系统肺胰脏---胰脏、睾丸胰脏和胰脏著者简介：Liaoyuan Li等概要：5522名片。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 暂时性中后期宫颈胰脏并作治疗后的除此以外治疗联席则会议: 护理人员肺胰脏著者简介： 李珉珉等概要：6031名片：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼外科手术心肌髓性胰脏的不确定性：基于ALTER01031实验的比对。则会话：肩部著者：济南市疗养院得意讲师概要：6526名片。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、大小和成年人对安洛替尼外科手术后病症结局的受到影响: ALTER01031的亚组比对联席则会议：肩部著者：济南市疗养院得意讲师概要：6527名片。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA比对数据分析I-IIIA期非小肝细胞肺胰脏（NSCLC）病症术后患: GASTO1035和GASTO1018的结果联席则会议：肺胰脏-非小肝细胞暂时性-周围性/小肝细胞/小肝细胞/其他胸科肺胰脏著者：Si-Yu Wang等概要：9023名片：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小肝细胞肺胰脏（NSCLC）中则会EGFR色氨酸嘌呤抑制的另行型耐药机制联席则会议:肺胰脏-非小肝细胞白血病肺胰脏著者简介：赵昕，金恰巧，满宇，欧赛金花，梅氏，薛武，杨少，范敏 赵昕、金恰巧、满宇、欧赛金花、梅氏、薛武、杨绍、范敏概要：9528名片：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1实验中则会中后期卵巢癌总猎食的替代往南联席则会议：卵巢癌/皮肤胰脏著者：聂润聪，袁书不强，李元芳，陈英波，周志伟 聂润聪、袁书不强、李元芳、陈英波、周志伟概要：10030名片：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼外科手术患或白血病原发性恶性穿孔病症的II期研究工作联席则会议： 白血病著者：唐丽娜，牛晓辉，王之震，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、王之振、蔡启庆、涂崇奇、范正福、杨瑶概要：11525名片。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 初步评论者安罗替尼在中后期白血病病症多线外科手术中则会的可靠度和。联席则会议：白血病著者：姚伟涛，王之家不强，姚，王之欣，杜另行辉，田志浩，牛晓颖 姚伟涛、王之家不强、姚、王之鑫、杜鑫辉、田志超、牛晓英概要：11526名片：414